发明名称 Pharmaceutical formulation of apomorphine for buccal administration
摘要 The present invention provides a kit comprising, in separate compartments of a container, the following components (a) and (b): (a) a combination of apomorphine or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable excipient or carrier; and (b) a solution which comprises a diluent and a pH modifying agent; the components being presented such that they can be combined at the point of use into a formulation which is adjusted to a pH ranging from mildly acidic to alkaline and which is suitable for buccal administration. The formulation is useful in treating Parkinson's disease and in promoting sexual function.
申请公布号 US8772309(B2) 申请公布日期 2014.07.08
申请号 US201213669148 申请日期 2012.11.05
申请人 Amarin Pharmaceuticals Ireland Limited 发明人 Clarke Anthony
分类号 A01N43/42;A61K31/44 主分类号 A01N43/42
代理机构 Dickinson Wright PLLC 代理人 Dickinson Wright PLLC
主权项 1. A method of buccally administering an apomorphine composition to a patient in need thereof, comprising: (a) at the time of administration, adding a diluent and a pH modifying agent to an apomorphine composition to form a liquid composition comprising a pharmaceutically effective amount of apomorphine or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable excipient or carrier and to adjust the pH of the liquid composition to a pH ranging from mildly acidic to alkaline, thereby forming a pH adjusted liquid composition; and then (b) introducing the resulting pH adjusted liquid composition to the mouth of a patient in need thereof, thereby buccally administering a pharmaceutically effective amount of apomorphine or a pharmaceutically acceptable acid salt thereof.
地址 Ballsbridge IE